The passing of tax reform led most analysts to predict that 2018 will be a strong year for mergers and acquisitions. Source: BioSpace

The proverbial glass ceiling for women in biotech has some cracks but it may not yet have shattered – particularly in the Bay Area hotbed. Source: BioSpace

According to the National Science Foundation (NSF), approximately 42% of life science professionals with doctorate degrees work in academia. Source: BioSpace

Teva Pharmaceuticals will close its offices in Washington, D.C. and New York City as part of the cost-cutting measures. Source: BioSpace

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) offered a negative opinion on Puma Biotechnology’s application for neratinib for breast cancer. Source: BioSpace

Life science companies are popular targets for securities fraud litigation. Source: BioSpace

Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending that two Pfizer hematology…

New York-based Kallyope Inc. has secured an additional $66 million in Series B funding that it will use to continue its work harnessing the communicative pathways between the digestive tract…

In an already competitive diabetes market, Novo Nordisk may have gained a significant edge with the results of its Phase III trial of GLP-1 drug Ozempic (semaglutide). Source: BioSpace

Novartis is eying a possible 2019 launch for RTH258 (brolucizumab), an ophthalmology drug for the treatment of neovascular age-related macular degeneration. Source: BioSpace